Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;7(6):552-559.
doi: 10.1016/S2468-1253(22)00008-5. Epub 2022 Apr 14.

The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas

Affiliations
Review

The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas

Luis Antonio Díaz et al. Lancet Gastroenterol Hepatol. 2022 Jun.

Abstract

Non-alcoholic fatty liver disease (NAFLD) affects 20-25% of the general population and is associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD risk factors are modifiable and, therefore, potentially amenable to being reduced by public health policies. To date, there is no information about NAFLD-related public health policies in the Americas. In this study, we analysed data from 17 American countries and found that none have established national public health policies to decrease NAFLD-related burden. There is notable heterogeneity in the existence of public health policies to prevent NAFLD-related conditions. The most common public health policies were related to diabetes (15 [88%] countries), hypertension (14 [82%] countries), cardiovascular diseases (14 [82%] countries), obesity (nine [53%] countries), and dyslipidaemia (six [35%] of countries). Only seven (41%) countries had a registry of the burden of NAFLD, and efforts to raise awareness in the Americas were scarce. The implementation of public health policies are urgently needed in the Americas to decrease the burden of NAFLD.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests NC-T received speaking fees from Bayer. The other authors declare no conflicts of interest.

Similar articles

Cited by

Publication types

LinkOut - more resources